NO318659B1 - Anvendelse av lipofile ekstrakter av rottene av Salvia miltiorrhyza Bunge for fremstilling av farmasoytiske sammensetninger til behandling av alkoholavhengighet. - Google Patents

Anvendelse av lipofile ekstrakter av rottene av Salvia miltiorrhyza Bunge for fremstilling av farmasoytiske sammensetninger til behandling av alkoholavhengighet. Download PDF

Info

Publication number
NO318659B1
NO318659B1 NO19975177A NO975177A NO318659B1 NO 318659 B1 NO318659 B1 NO 318659B1 NO 19975177 A NO19975177 A NO 19975177A NO 975177 A NO975177 A NO 975177A NO 318659 B1 NO318659 B1 NO 318659B1
Authority
NO
Norway
Prior art keywords
alcohol
treatment
rats
salvia
extract
Prior art date
Application number
NO19975177A
Other languages
English (en)
Norwegian (no)
Other versions
NO975177D0 (no
NO975177L (no
Inventor
Ezio Bombardelli
Paolo Morazzoni
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of NO975177D0 publication Critical patent/NO975177D0/no
Publication of NO975177L publication Critical patent/NO975177L/no
Publication of NO318659B1 publication Critical patent/NO318659B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Addiction (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Medicinal Preparation (AREA)
NO19975177A 1995-05-12 1997-11-11 Anvendelse av lipofile ekstrakter av rottene av Salvia miltiorrhyza Bunge for fremstilling av farmasoytiske sammensetninger til behandling av alkoholavhengighet. NO318659B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI950958A IT1274481B (it) 1995-05-12 1995-05-12 Composizioni farmaceutiche per il trattamento della alcol-dipendenza
PCT/EP1996/001916 WO1996035441A1 (en) 1995-05-12 1996-05-08 Pharmaceutical compositions for the treatment of alcohol addiction

Publications (3)

Publication Number Publication Date
NO975177D0 NO975177D0 (no) 1997-11-11
NO975177L NO975177L (no) 1997-11-11
NO318659B1 true NO318659B1 (no) 2005-04-25

Family

ID=11371582

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19975177A NO318659B1 (no) 1995-05-12 1997-11-11 Anvendelse av lipofile ekstrakter av rottene av Salvia miltiorrhyza Bunge for fremstilling av farmasoytiske sammensetninger til behandling av alkoholavhengighet.

Country Status (16)

Country Link
US (1) US5904923A (de)
EP (1) EP0824356B1 (de)
JP (1) JP2955370B2 (de)
KR (1) KR100290029B1 (de)
CN (1) CN1066336C (de)
AT (1) ATE221384T1 (de)
AU (1) AU695010B2 (de)
CA (1) CA2220703C (de)
DE (1) DE69622704T2 (de)
DK (1) DK0824356T3 (de)
ES (1) ES2180783T3 (de)
IT (1) IT1274481B (de)
NO (1) NO318659B1 (de)
PT (1) PT824356E (de)
RU (1) RU2153345C2 (de)
WO (1) WO1996035441A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ298532B6 (cs) 1997-07-30 2007-10-31 Indena S. P. A. Sójový extrakt, zpusob jeho prípravy a farmaceutický prostredek, který jej obsahuje
US5968746A (en) 1997-11-26 1999-10-19 Schneider; David R. Method and apparatus for preserving human saliva for testing
AU2001286409A1 (en) * 2000-08-03 2002-02-18 Hong Kong University Of Science And Technology N-methyl-d-aspartate receptor antagonists
CN1304723A (zh) * 2001-01-16 2001-07-25 中山大学 含二氢呋喃环结构的丹参酮类化合物用于治疗肝性脑病的药物
US6852342B2 (en) * 2002-03-26 2005-02-08 Avoca, Inc. Compounds for altering food intake in humans
WO2004058245A1 (fr) * 2002-12-31 2004-07-15 Zhongshan Univertsity Utilisation de la tanshinone iia dans la prophylaxie ou le traitement de l'atherosclerose
US9827314B2 (en) * 2003-12-08 2017-11-28 Mars, Incorporated Edible compositions which are adapted for use by a companion animal
JP2008538748A (ja) * 2005-04-07 2008-11-06 ハイシアム， インコーポレイテッド 不安、物質乱用及び依存の予防のための改良型方法及び組成物
GB201312205D0 (en) * 2013-07-08 2013-08-21 Univ Leuven Kath Anticonvulsant activity of dan shen extracting compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1239281B (it) * 1989-10-27 1993-10-19 Indena Spa Composizioni per la riduzione dei depositi di grasso superfluo a base di principi attivi di origine vegetale ad attivita' agonista dell'adenilato ciclasi o/e ad attivita' antifosfodiesterasica
RU2011382C1 (ru) * 1989-11-20 1994-04-30 Научно-исследовательский институт фармакологии Томского научного центра РАН Антиалкогольное средство
US5204369A (en) * 1991-07-01 1993-04-20 The Endowment For Research In Human Biology Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse

Also Published As

Publication number Publication date
DE69622704T2 (de) 2003-04-03
ES2180783T3 (es) 2003-02-16
HK1009096A1 (en) 1999-05-28
CN1066336C (zh) 2001-05-30
JP2955370B2 (ja) 1999-10-04
WO1996035441A1 (en) 1996-11-14
DK0824356T3 (da) 2002-11-25
NO975177D0 (no) 1997-11-11
AU695010B2 (en) 1998-08-06
AU5815396A (en) 1996-11-29
PT824356E (pt) 2002-12-31
CN1184429A (zh) 1998-06-10
CA2220703A1 (en) 1996-11-14
CA2220703C (en) 2001-07-24
ITMI950958A1 (it) 1996-11-12
KR19990014692A (ko) 1999-02-25
EP0824356B1 (de) 2002-07-31
IT1274481B (it) 1997-07-17
RU2153345C2 (ru) 2000-07-27
KR100290029B1 (ko) 2001-05-15
EP0824356A1 (de) 1998-02-25
US5904923A (en) 1999-05-18
ATE221384T1 (de) 2002-08-15
JPH10512583A (ja) 1998-12-02
NO975177L (no) 1997-11-11
DE69622704D1 (de) 2002-09-05
ITMI950958A0 (it) 1995-05-12

Similar Documents

Publication Publication Date Title
Patočka et al. Biomedically relevant chemical constituents of Valeriana officinalis
Bilia et al. St. John's wort and depression: efficacy, safety and tolerability-an update
KR100360674B1 (ko) 치매 예방 및 치료제 조성물
Germanò et al. Hepatoprotective activity of Trichilia roka on carbon tetrachloride‐induced liver damage in rats
Kassis et al. Efficacy and safety assessments of Ferula assa-foetida L., traditionally used in Greco-Arab herbal medicine for enhancing male fertility, libido and erectile function
NO318659B1 (no) Anvendelse av lipofile ekstrakter av rottene av Salvia miltiorrhyza Bunge for fremstilling av farmasoytiske sammensetninger til behandling av alkoholavhengighet.
Tharakan et al. Botanical therapies in sexual dysfunction
KR101189108B1 (ko) 황칠나무 추출물을 포함하는 남성 성기능 개선용 조성물
JP3091962B2 (ja) テストステロン−５α−レダクターゼ阻害剤
KR100378735B1 (ko) 원지로부터 유효성분의 추출·정제방법 및 그 추출물을함유한 치매치료용 생약 조성물
KR100523440B1 (ko) 자생 식물로부터 얻은 비만 및 당뇨병 치료 추출물
CN112870290A (zh) 一种祛斑解郁组合物及其制备方法
CN100522193C (zh) 构树果色素的用途
Shimada et al. Choto-san prevents occurrence of stroke and prolongs life span in stroke-prone spontaneously hypertensive rats
KR20040016579A (ko) 비만 및 당뇨병 예방 및 치료효과를 보이는 자생식물 추출물
KR20010100548A (ko) 지실로부터 유효성분의 추출·정제방법 및 그 추출물을함유한 치매치료용 생약 조성물
KR20040047617A (ko) 니코틴제거 효과가 있는 조성물 및 그 제조 방법
Sirohi et al. CNS activity of hydroalcohalic extract of Bombax ceiba flower
KR20040016578A (ko) 항비만 및 항당뇨효과를 보이는 자생식물 추출물
Khan et al. Formulation and evaluation of herbal chocolate from Arjuna Bark treatment of heart disease condition
Saltanat et al. Analysis of Hirsutism as a Symptom of Ihtibās al-Tamth (Amenorrhea) and its Relation to Polycystic Ovary Syndrome
HK1009096B (en) Pharmaceutical compositions for the treatment of alcohol addiction
KR20220011254A (ko) 정어리 추출물을 포함하는 남성 성기능 개선용 조성물
JPH11500738A (ja) アルコール嗜癖の治療のための薬剤の製造におけるフォルスコリンまたはそれを含んでいる抽出物の使用
Zhang et al. The herbal medicine tian ma gou teng yen alters the development of high blood pressure in the spontaneously hypertensive rat

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees